This article is an erratum on:
Modulation of Gut Microbiota by Magnesium Isoglycyrrhizinate Mediates Enhancement of Intestinal Barrier Function and Amelioration of Methotrexate-Induced Liver Injury
Frontiers Production OfficeBy Xia Y, Shi H, Qian C, Han H, Lu K, Tao R, Gu R, Zhao Y, Wei Z and Lu Y (2022) 13:874878. doi: 10.3389/fimmu.2022.874878
Due to a production error, the Acknowledgements section was not included in the article. The acknowledgements section should read:
“ The authors thank Nanjing Jiangbei New Area Biopharmaceutical Public Service Platform for the quantification of Short-Chain Fatty Acids. Many thanks to Pro. Lu, our academic and life mentor, for strong spiritual support.”
The original version of this article has been updated.
Keywords: methotrexate, magnesium isoglycyrrhizinate, gut-liver axis, bacterial translocation, gut microbiota
Citation: Frontiers Production Office (2022) Erratum: Modulation of Gut Microbiota by Magnesium Isoglycyrrhizinate Mediates Enhancement of Intestinal Barrier Function and Amelioration of Methotrexate-Induced Liver Injury. Front. Immunol. 13:976502. doi: 10.3389/fimmu.2022.976502
Received: 23 June 2022; Accepted: 23 June 2022;
Published: 04 July 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: production.office@frontiersin.org